Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Recovery of second trimester pre-eclampsia after fetal reduction of a triplet.

Bij de Weg JM, de Groot CJ, Pajkrt E, de Boer MA.

BMJ Case Rep. 2019 Sep 18;12(9). pii: e227667. doi: 10.1136/bcr-2018-227667.

PMID:
31537585
2.

Analysis of Publication Interest on Preterm Birth Over Two Decades.

Visser L, de Boer MA, de Groot CJM.

Matern Child Health J. 2019 Oct;23(10):1392-1399. doi: 10.1007/s10995-019-02772-x.

3.

Publication bias may exist among prognostic accuracy studies of middle cerebral artery Doppler ultrasound.

Vollgraff Heidweiller-Schreurs CA, Korevaar DA, Mol BWJ, Bax CJ, de Groot CJM, de Boer MA, Bossuyt PMM.

J Clin Epidemiol. 2019 Jul 30;116:1-8. doi: 10.1016/j.jclinepi.2019.07.016. [Epub ahead of print] Review.

PMID:
31374330
4.

Women's experiences of monitoring the small-for-gestational age fetus by ultrasound: A qualitative study.

Vollgraff Heidweiller-Schreurs CA, de Boer MA, van der Meij KRM, Bax CJ, de Groot CJM, Henneman L.

PLoS One. 2019 May 1;14(5):e0216052. doi: 10.1371/journal.pone.0216052. eCollection 2019.

5.

The prognostic accuracy of short term variation of fetal heart rate in early-onset fetal growth restriction: A systematic review.

Pels A, Mensing van Charante NA, Vollgraff Heidweiller-Schreurs CA, Limpens J, Wolf H, de Boer MA, Ganzevoort W.

Eur J Obstet Gynecol Reprod Biol. 2019 Mar;234:179-184. doi: 10.1016/j.ejogrb.2019.01.005. Epub 2019 Jan 22.

PMID:
30710764
6.

Cost effectiveness of nifedipine compared with atosiban in the treatment of threatened preterm birth (APOSTEL III trial).

Nijman T, van Baaren GJ, van Vliet E, Kok M, Gyselaers W, Porath MM, Woiski M, de Boer MA, Bloemenkamp K, Sueters M, Franx A, Mol B, Oudijk MA.

BJOG. 2019 Jun;126(7):875-883. doi: 10.1111/1471-0528.15625. Epub 2019 Mar 27.

PMID:
30666783
7.

Risk of chronic ankle instability: A reliability study on radiographic assessment of the ankle joint geometry.

Vuurberg G, Wink LM, Sierevelt IN, Jens S, Hemke R, de Boer MA, den Butter E, Kerkhoffs GMMJ, Maas M.

Foot (Edinb). 2019 Mar;38:12-18. doi: 10.1016/j.foot.2018.11.001. Epub 2018 Nov 6.

PMID:
30530188
8.

Comment on "Application of Struvite Alters the Antibiotic Resistome in Soil, Rhizosphere, and Phyllosphere".

de Boer MA, Kabbe C, Slootweg JC.

Environ Sci Technol. 2018 Dec 18;52(24):14564-14565. doi: 10.1021/acs.est.8b03524. Epub 2018 Nov 21. No abstract available.

9.

Doppler measurements of both umbilical arteries do not improve predictive value for adverse perinatal outcomes in small-for-gestational age fetuses.

Vollgraff Heidweiller-Schreurs CA, van Maasakker NE, van de Ven PM, de Groot CJM, Bax CJ, de Boer MA.

Eur J Obstet Gynecol Reprod Biol. 2018 Dec;231:169-173. doi: 10.1016/j.ejogrb.2018.10.040. Epub 2018 Oct 25.

PMID:
30391865
10.

Cervical Pessary After Arrested Preterm Labor: A Randomized Controlled Trial.

Hermans FJR, Schuit E, Bekker MN, Woiski M, de Boer MA, Sueters M, Scheepers HCJ, Franssen MTM, Pajkrt E, Mol BWJ, Kok M.

Obstet Gynecol. 2018 Sep;132(3):741-749. doi: 10.1097/AOG.0000000000002798.

PMID:
30095769
11.

Uptake of pharmaceuticals by sorbent-amended struvite fertilisers recovered from human urine and their bioaccumulation in tomato fruit.

de Boer MA, Hammerton M, Slootweg JC.

Water Res. 2018 Apr 15;133:19-26. doi: 10.1016/j.watres.2018.01.017. Epub 2018 Jan 10.

12.

Maternal and Perinatal Outcome in Women with Systemic Lupus Erythematosus: A Retrospective Bicenter Cohort Study.

Kroese SJ, Abheiden CNH, Blomjous BS, van Laar JM, Derksen RWHM, Bultink IEM, Voskuyl AE, Lely AT, de Boer MA, de Vries JIP, Fritsch-Stork RDE.

J Immunol Res. 2017;2017:8245879. doi: 10.1155/2017/8245879. Epub 2017 Sep 28.

13.

Introduction of non-invasive prenatal testing as a first-tier aneuploidy screening test: A survey among Dutch midwives about their role as counsellors.

Martin L, Gitsels-van der Wal JT, de Boer MA, Vanstone M, Henneman L.

Midwifery. 2018 Jan;56:1-8. doi: 10.1016/j.midw.2017.09.008. Epub 2017 Sep 24.

PMID:
29024868
14.

Pessary or Progesterone to Prevent Preterm delivery in women with short cervical length: the Quadruple P randomised controlled trial.

van Zijl MD, Koullali B, Naaktgeboren CA, Schuit E, Bekedam DJ, Moll E, Oudijk MA, van Baal WM, de Boer MA, Visser H, van Drongelen J, van de Made FW, Vollebregt KC, Muller MA, Bekker MN, Brons JTJ, Sueters M, Langenveld J, Franssen MT, Schuitemaker NW, van Beek E, Scheepers HCJ, de Boer K, Tepe EM, Huisjes AJM, Hooker AB, Verheijen ECJ, Papatsonis DN, Mol BWJ, Kazemier BM, Pajkrt E.

BMC Pregnancy Childbirth. 2017 Sep 4;17(1):284. doi: 10.1186/s12884-017-1454-x.

15.

Prognostic accuracy of cerebroplacental ratio and middle cerebral artery Doppler for adverse perinatal outcome: systematic review and meta-analysis.

Vollgraff Heidweiller-Schreurs CA, De Boer MA, Heymans MW, Schoonmade LJ, Bossuyt PMM, Mol BWJ, De Groot CJM, Bax CJ.

Ultrasound Obstet Gynecol. 2018 Mar;51(3):313-322. doi: 10.1002/uog.18809. Epub 2018 Feb 5. Review.

16.

Low dose aspirin in the prevention of recurrent spontaneous preterm labour - the APRIL study: a multicenter randomized placebo controlled trial.

Visser L, de Boer MA, de Groot CJM, Nijman TAJ, Hemels MAC, Bloemenkamp KWM, Bosmans JE, Kok M, van Laar JO, Sueters M, Scheepers H, van Drongelen J, Franssen MTM, Sikkema JM, Duvekot HJJ, Bekker MN, van der Post JAM, Naaktgeboren C, Mol BWJ, Oudijk MA.

BMC Pregnancy Childbirth. 2017 Jul 14;17(1):223. doi: 10.1186/s12884-017-1338-0.

17.

A multi-centre, non-inferiority, randomised controlled trial to compare a cervical pessary with a cervical cerclage in the prevention of preterm delivery in women with short cervical length and a history of preterm birth - PC study.

Koullali B, van Kempen LEM, van Zijl MD, Naaktgeboren CA, Schuit E, Bekedam DJ, Franssen MTM, Nij Bijvank SWA, Sueters M, van Baal M, de Boer MA, Hooker AB, Hermsen BBJ, Toolenaar TAAM, Zwart JJ, van der Ham DP, van der Made FW, Prefumo F, Martinez de Tejada B, Papatsonis DNM, Huisjes AJM, Scheepers LHCJ, van Hoorn ME, Hasaart THM, Schuitemaker NWE, Vollebregt KC, Müller MA, Evers IM, Post MS, de Boer K, Visser H, Mensing van Charante NA, Langenveld J, Steemers NYC, Mol BWJ, Oudijk MA, Pajkrt E.

BMC Pregnancy Childbirth. 2017 Jul 6;17(1):215. doi: 10.1186/s12884-017-1393-6. No abstract available.

18.

Women's Experience with Non-Invasive Prenatal Testing and Emotional Well-being and Satisfaction after Test-Results.

van Schendel RV, Page-Christiaens GCML, Beulen L, Bilardo CM, de Boer MA, Coumans ABC, Faas BHW, van Langen IM, Lichtenbelt KD, van Maarle MC, Macville MVE, Oepkes D, Pajkrt E, Henneman L; Dutch NIPT Consortium.

J Genet Couns. 2017 Dec;26(6):1348-1356. doi: 10.1007/s10897-017-0118-3. Epub 2017 Jun 30.

19.

Caesarean section increases risk of preterm birth in subsequent pregnancy.

Visser L, de Boer MA, Mol BW.

Evid Based Nurs. 2017 Apr;20(2):42. doi: 10.1136/eb-2016-102586. Epub 2017 Mar 2. No abstract available.

PMID:
28255073
20.

What do people want to know about NIPT? Content analysis of questions emailed to national NIPT information websites.

Tamminga S, van Dussen L, Verweij EJ, de Boer MA, Cornel MC, Henneman L; Dutch NIPT Consortium.

Prenat Diagn. 2017 Apr;37(4):412-415. doi: 10.1002/pd.5011. Epub 2017 Feb 28. No abstract available.

21.

Re: Consensus definition for placental fetal growth restriction: a Delphi procedure.

Schreurs CA, Mol BW, de Boer MA.

Ultrasound Obstet Gynecol. 2017 Jan;49(1):159. doi: 10.1002/uog.17321. No abstract available.

22.

Post-pregnancy aspirin resistance appears not to be related with recurrent hypertensive disorders of pregnancy.

Abheiden CNH, Fuijkschot WW, Arduç A, van Diemen JJK, Harmsze AM, de Boer MA, Thijs A, de Vries JIP.

Eur J Obstet Gynecol Reprod Biol. 2017 Mar;210:139-143. doi: 10.1016/j.ejogrb.2016.12.023. Epub 2016 Dec 21.

PMID:
28033561
23.

Aspirin adherence during high-risk pregnancies, a questionnaire study.

Abheiden CN, van Reuler AV, Fuijkschot WW, de Vries JI, Thijs A, de Boer MA.

Pregnancy Hypertens. 2016 Oct;6(4):350-355. doi: 10.1016/j.preghy.2016.08.232. Epub 2016 Aug 6.

PMID:
27939481
24.

Cardiovascular risk factors in women with inheritable thrombophilia a decade after single or recurrent hypertensive disorder of pregnancy.

Abheiden CN, Thijs A, de Vries JI, de Boer MA.

Hypertens Pregnancy. 2016 Nov;35(4):461-469. Epub 2016 Jun 20.

PMID:
27322349
25.

Trial by Dutch laboratories for evaluation of non-invasive prenatal testing. Part II-women's perspectives.

van Schendel RV, Page-Christiaens GC, Beulen L, Bilardo CM, de Boer MA, Coumans AB, Faas BH, van Langen IM, Lichtenbelt KD, van Maarle MC, Macville MV, Oepkes D, Pajkrt E, Henneman L; Dutch NIPT Consortium.

Prenat Diagn. 2016 Dec;36(12):1091-1098. doi: 10.1002/pd.4941. Epub 2016 Nov 16.

26.

Spontaneous haemoperitoneum in pregnancy and endometriosis: a case series.

Lier M, Malik RF, van Waesberghe J, Maas JW, van Rumpt-van de Geest DA, Coppus SF, Berger JP, van Rijn BB, Janssen PF, de Boer MA, de Vries J, Jansen FW, Brosens IA, Lambalk CB, Mijatovic V.

BJOG. 2017 Jan;124(2):306-312. doi: 10.1111/1471-0528.14371. Epub 2016 Oct 5.

27.

Low-molecular-weight heparin and aspirin use in relation to pregnancy outcome in women with systemic lupus erythematosus and antiphospholipid syndrome: A cohort study.

Abheiden CN, Blomjous BS, Kroese SJ, Bultink IE, Fritsch-Stork RD, Lely AT, de Boer MA, de Vries JI.

Hypertens Pregnancy. 2017 Feb;36(1):8-15. doi: 10.1080/10641955.2016.1217337. Epub 2016 Sep 6.

PMID:
27599157
28.

Chromosomal abnormalities and copy number variations in fetal left-sided congenital heart defects.

Jansen FA, Hoffer MJ, van Velzen CL, Plati SK, Rijlaarsdam ME, Clur SA, Blom NA, Pajkrt E, Bhola SL, Knegt AC, de Boer MA, Haak MC.

Prenat Diagn. 2016 Feb;36(2):177-85. doi: 10.1002/pd.4767. Epub 2016 Feb 3.

PMID:
26716421
29.

Non-invasive prenatal testing for trisomy 13: more harm than good?

Verweij EJ, de Boer MA, Oepkes D.

Ultrasound Obstet Gynecol. 2014 Jul;44(1):112-4. doi: 10.1002/uog.13388.

30.

Non-invasive prenatal screening for trisomy 21: what women want and are willing to pay.

Verweij EJ, Oepkes D, de Vries M, van den Akker ME, van den Akker ES, de Boer MA.

Patient Educ Couns. 2013 Dec;93(3):641-5. doi: 10.1016/j.pec.2013.08.006. Epub 2013 Aug 19.

PMID:
24011429
31.

Scarcity of rare earth elements.

de Boer MA, Lammertsma K.

ChemSusChem. 2013 Nov;6(11):2045-55. doi: 10.1002/cssc.201200794. Epub 2013 Sep 5.

PMID:
24009098
32.

European non-invasive trisomy evaluation (EU-NITE) study: a multicenter prospective cohort study for non-invasive fetal trisomy 21 testing.

Verweij EJ, Jacobsson B, van Scheltema PA, de Boer MA, Hoffer MJ, Hollemon D, Westgren M, Song K, Oepkes D.

Prenat Diagn. 2013 Oct;33(10):996-1001. doi: 10.1002/pd.4182. Epub 2013 Jul 21.

PMID:
23794121
33.

Changing attitudes towards termination of pregnancy for trisomy 21 with non-invasive prenatal trisomy testing: a population-based study in Dutch pregnant women.

Verweij EJ, Oepkes D, de Boer MA.

Prenat Diagn. 2013 Apr;33(4):397-9. doi: 10.1002/pd.4063. Epub 2013 Feb 14. No abstract available.

PMID:
23408587
34.

Non-invasive prenatal diagnosis for Down syndrome: no paradigm shift, just better testing... and it is already here!

Verweij EJ, de Boer MA, Oepkes D.

Ultrasound Obstet Gynecol. 2012 Oct;40(4):484-5; author reply 485-6. doi: 10.1002/uog.12287. No abstract available.

35.

Effects of naloxone on the breathing pattern of a newborn exposed to maternal opiates.

van Vonderen JJ, Siew ML, Hooper SB, de Boer MA, Walther FJ, te Pas AB.

Acta Paediatr. 2012 Jul;101(7):e309-12. doi: 10.1111/j.1651-2227.2012.02649.x. Epub 2012 Mar 27.

PMID:
22372574
36.

Diagnostic accuracy of noninvasive detection of fetal trisomy 21 in maternal blood: a systematic review.

Verweij EJ, van den Oever JM, de Boer MA, Boon EM, Oepkes D.

Fetal Diagn Ther. 2012;31(2):81-6. doi: 10.1159/000333060. Epub 2011 Nov 17. Review.

37.

Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil.

Mouchaers KT, Schalij I, de Boer MA, Postmus PE, van Hinsbergh VW, van Nieuw Amerongen GP, Vonk Noordegraaf A, van der Laarse WJ.

Eur Respir J. 2010 Oct;36(4):800-7. doi: 10.1183/09031936.00130209. Epub 2010 Mar 29.

38.

Prevalence of human papillomavirus in Indonesia: a population-based study in three regions.

Vet JN, de Boer MA, van den Akker BE, Siregar B, Lisnawati, Budiningsih S, Tyasmorowati D, Moestikaningsih, Cornain S, Peters AA, Fleuren GJ.

Br J Cancer. 2008 Jul 8;99(1):214-8.

39.

Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts.

de Boer MA, Jordanova ES, van Poelgeest MI, van den Akker BE, van der Burg SH, Kenter GG, Fleuren GJ.

Int J Cancer. 2007 Dec 15;121(12):2711-5.

40.

High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.

de Boer MA, Jordanova ES, Kenter GG, Peters AA, Corver WE, Trimbos JB, Fleuren GJ.

Clin Cancer Res. 2007 Jan 1;13(1):132-8.

41.

Human papillomavirus type 18 and other risk factors for cervical cancer in Jakarta, Indonesia.

de Boer MA, Vet JN, Aziz MF, Cornain S, Purwoto G, van den Akker BE, Dijkman A, Peters AA, Fleuren GJ.

Int J Gynecol Cancer. 2006 Sep-Oct;16(5):1809-14.

PMID:
17009976
42.

[Foeto-foetal conflict of interests in multiple pregnancies with severe discordant growth; ethical dilemmas].

de Boer MA, van Huisseling JC, van Roosmalen J.

Ned Tijdschr Geneeskd. 2005 Jun 18;149(25):1369-72. Dutch.

PMID:
15997687
43.

Human papillomavirus type 18 variants: histopathology and E6/E7 polymorphisms in three countries.

De Boer MA, Peters LA, Aziz MF, Siregar B, Cornain S, Vrede MA, Jordanova ES, Fleuren GJ.

Int J Cancer. 2005 Apr 10;114(3):422-5. Erratum in: Int J Cancer. 2005 May 10;114(6):1016.

44.

Human papillomavirus type 16 E6, E7, and L1 variants in cervical cancer in Indonesia, Suriname, and The Netherlands.

de Boer MA, Peters LA, Aziz MF, Siregar B, Cornain S, Vrede MA, Jordanova ES, Kolkman-Uljee S, Fleuren GJ.

Gynecol Oncol. 2004 Aug;94(2):488-94.

PMID:
15297193
45.

Intrahippocampal administration of the alpha-keto acids accumulating in maple syrup urine disease provokes learning deficits in rats.

de Castro Vasques V, de Boer MA, Diligenti F, Brinco F, Mallmann F, Mello CF, Wajner M.

Pharmacol Biochem Behav. 2004 Jan;77(1):183-90.

PMID:
14724056
46.

Sulprostone for pregnancy termination in women with severe (pre-) eclampsia.

van Gemund N, de Boer MA, van Selm M, Scherjon SA, Kanhai HH.

Hypertens Pregnancy. 2002;21(2):115-22.

PMID:
12175439
47.

Low dose sulprostone for termination of second and third trimester pregnancies.

de Boer MA, van Gemund N, Scherjon SA, Kanhai HH.

Eur J Obstet Gynecol Reprod Biol. 2001 Dec 1;99(2):244-8.

PMID:
11788180
48.

Factors influencing marital stability among HIV discordant couples in northern Thailand.

Tangmunkongvorakul A, Celentano DD, Burke JG, de Boer MA, Wongpan P, Suriyanon V.

AIDS Care. 1999 Oct;11(5):511-24.

PMID:
10755027
49.

High rates of transmission of subtype E human immunodeficiency virus type 1 among heterosexual couples in Northern Thailand: role of sexually transmitted diseases and immune compromise.

Nelson KE, Rungruengthanakit K, Margolick J, Suriyanon V, Niyomthai S, de Boer MA, Kawichai S, Robison V, Celentano DD, Nagachinta T, Duerr A.

J Infect Dis. 1999 Aug;180(2):337-43. Erratum in: J Infect Dis 1999 Nov;180(5):1756.

PMID:
10395847
50.

Reliability of self-reported sexual behavior in human immunodeficiency virus (HIV) concordant and discordant heterosexual couples in northern Thailand.

de Boer MA, Celentano DD, Tovanabutra S, Rugpao S, Nelson KE, Suriyanon V.

Am J Epidemiol. 1998 Jun 15;147(12):1153-61.

PMID:
9645794

Supplemental Content

Loading ...
Support Center